Although molecular testing showed that the anaplastic lymphoma kinase (ALK) gene of the tumor did not undergo breakage and recombination, the histological and immunohistochemical findings were consistent with a diagnosis of IMT (Fig. 3, Additional file 1). Here, ALK is linked to inflammatory myofibroblastic tumor.